Merck

Latest Articles

Daily Agenda: Bank of Japan Disappoints Market

Andrew Barber July 29, 2016

Investing in a Cure for Cancer

Kaitlin Ugolik June 7, 2016

2016-03-vitaliy-katsenelson-gilead-sciences-lab-worker-large.jpg

Gilead Sciences’ Miracle Drug Combination

Vitaliy Katsenelson February 23, 2016

Daily Agenda: The Week Ahead, February 1—7, 2016

Andrew Barber January 30, 2016

AbbVie Enters the Battle of the Biosimilars

Khadijah M Silver January 15, 2016

Sex-for-Life Testosterone Boost Fueling Safety Concerns: Health

Aggressive Pharma Ads Yield Results — and Complaints

Khadijah M Silver December 4, 2015

Daily Agenda: The Week Ahead, July 27 – August 1, 2015

Andrew Barber July 25, 2015

Daily Agenda: Oil Prices Finding Footing

Andrew Barber February 4, 2015

Daily Agenda: Are European Banks Failing the Test?

Andrew Barber October 27, 2014

Daily Agenda: Tesco Launches Investigation into Profit Overstatement

Andrew Barber September 22, 2014

Merck Offers $7.2 Billion For Millipore

March 2, 2010

Merck Looks To Recent Schering-Plough Merger For New Drug

Fran Hawthorne February 10, 2010

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Market Intelligence

Data & Analysis

Guest Contributors

II Networks

Insights

Research

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.01 build:2025-12-11 Login